A 32-year-old woman from Mumbai presents with primary infertility of 4 years. She reports menarche at age 14, regular menstrual cycles until age 28, then progressive oligomenorrhea (cycles now 45–60 days apart). She denies hot flushes, night sweats, or mood changes. On examination, BMI 22 kg/m², normal secondary sexual characteristics, no galactorrhea. Transvaginal ultrasound shows small, fibrotic ovaries with few or no visible follicles. Serum FSH 68 mIU/mL, LH 52 mIU/mL, estradiol <20 pg/mL, anti-Müllerian hormone (AMH) <0.5 ng/mL. Karyotype is 46,XX. What is the most likely diagnosis?

Explanation

## Diagnosis: Premature Ovarian Insufficiency (POI) ### Definition & Epidemiology **Key Point:** Premature ovarian insufficiency (POI, formerly premature ovarian failure) is defined as: - Loss of ovarian function before age 40 - Elevated FSH (>40 mIU/mL on two occasions ≥4 weeks apart) - Low estradiol (<50 pg/mL) - Oligomenorrhea or amenorrhea - Normal 46,XX karyotype **High-Yield:** POI affects 1–2% of women <40 years. It is the second most common cause of secondary infertility after PCOS. ### Diagnostic Criteria Met in This Case | Parameter | Finding | Normal Range | Status | |-----------|---------|--------------|--------| | **Age at onset** | 28 years (progressive oligomenorrhea) | — | ✓ <40 years | | **FSH** | 68 mIU/mL | 5–25 (follicular) | ✓ Markedly elevated | | **LH** | 52 mIU/mL | 5–25 (follicular) | ✓ Elevated | | **Estradiol** | <20 pg/mL | >30 (follicular) | ✓ Low | | **AMH** | <0.5 ng/mL | >1.0 (reproductive age) | ✓ Severely low | | **Ovarian morphology** | Small, fibrotic, few follicles | — | ✓ Consistent | | **Karyotype** | 46,XX | — | ✓ Normal | **Clinical Pearl:** AMH <0.5 ng/mL indicates severely diminished ovarian reserve and is highly specific for POI. AMH is produced by granulosa cells of small follicles and reflects the size of the primordial follicle pool. ### Pathophysiology & Etiology ```mermaid flowchart TD A[Accelerated Follicle Atresia]:::outcome --> B[↓ Primordial Follicle Pool]:::outcome B --> C[↓ Inhibin B & AMH]:::outcome C --> D[Loss of negative feedback on pituitary]:::action D --> E[↑ FSH & LH]:::outcome E --> F[Inadequate follicle development]:::outcome F --> G[Oligomenorrhea/Amenorrhea & Infertility]:::urgent H[Autoimmune, genetic, or idiopathic mechanisms]:::outcome --> A ``` ### Causes of POI (Differential) **Mnemonic: AAGI** (Autoimmune, Anatomic, Genetic, Iatrogenic) - **Autoimmune:** Anti-ovarian antibodies, Addison disease, thyroid disease - **Anatomic:** Uterine artery embolization, ovarian surgery - **Genetic:** FMR1 premutation, Turner mosaicism, galactosemia - **Iatrogenic:** Chemotherapy, radiotherapy, ovarian surgery - **Idiopathic:** ~70% of cases **Screening recommended:** TSH, tissue transglutaminase (tTG-IgA) for celiac disease, adrenal antibodies if clinical suspicion. ### Management 1. **Hormone replacement therapy (HRT):** Estrogen + progestin to prevent osteoporosis and cardiovascular disease (POI increases fracture and CVD risk) 2. **Fertility options:** - Assisted reproductive technology (ART) with donor oocytes (highest success rate, ~50–60% per cycle) - Spontaneous pregnancy still possible in 5–10% of POI patients (intermittent ovulation) 3. **Psychosocial support:** Infertility + premature menopause is emotionally significant [cite:ESHRE POI Guideline 2016; Textbook of Reproductive Medicine]